Virtu Financial’s Greenwich LifeSciences GLSI Stock Holding History

Virtu Financial’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,797	Closed	-$605K	–	1879
2025 Q4	$605K	Buy	+28,797	New	+$303K	0.02%	523

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Virtu Financial's GLSI Position: Q1 2026 in Review

Virtu Financial sold out of Greenwich LifeSciences (GLSI) in Q1 2026, closing a stake of 28,797 shares — an estimated $605K sold.

Virtu Financial first reported a position in GLSI in Q4 2025 and held it in 1 quarter. The position peaked at $605K in Q4 2025. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

Virtu Financial reported no remaining Greenwich LifeSciences position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 28,797 Greenwich LifeSciences shares in Q1 2026, an estimated $605K.
Virtu Financial first reported a position in Greenwich LifeSciences in Q4 2025 and held it in 1 quarter.
Virtu Financial's Greenwich LifeSciences position peaked at $605K in Q4 2025.
64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.